How digital health impacts the development and adoption of cancer immunotherapies

Essential to the future of cancer immunotherapies is a digital health infrastructure that can support reliable, secure and compliant data collection from disparate systems and devices. As more and more immuno-oncology (IO) treatments come to market, biopharma will require data to enable more efficient research and development; providers will require data to drive more personalized treatments and payers will require data that enables them to make informed decisions about which therapies to cover.
Read more...

;